Science

Mar 21, 2025, 09:31

Myeloma Paper of the Day, March 21st, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Clonal hematopoiesis frequently co-exists with myeloma at diagnosis, associates with more advanced stage, age, decreased naive T cells, a pro-inflammatory TME, decreased DC antigen-presenting function and exhaustion markers in CD8 cells.”

“Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes”

Authors: Marta Lionetti, Margherita Scopetti, Antonio Matera, Akihiro Maeda, Alessio Marella, Elisa Taiana, Claudio De Magistris, Matteo Claudio Da Via’, Francesco Passamonti, Niccolò Bolli et al.

More posts featuring Robert Orlowski.

Akihiro Maeda Alessio Marella Antonio Matera cancer Claudio De Magistris clonal hematopoiesis Elisa Taiana Francesco Passamonti Margherita Scopetti Marta Lionetti Matteo Claudio Da Via' multiple myeloma Myeloma Paper of the Day Niccolò Bolli OncoDaily Oncology Robert Orlowski

April is Head and Neck Cancer Awareness Month

Is Cancer Hereditary? Myths and Facts about Cancer Genetics

Neuroendocrine Lung Tumors: Types, Symptoms, Diagnosis, Treatment and 2025 updates

Cancer Center Near Me: Dana-Farber Cancer Institute

FDA Approves Nivolumab and Ipilimumab for First-Line Treatment of Unresectable Hepatocellular Carcinoma Based on CheckMate-9DW Trial